Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,365.70
-43.90 (-3.11%)
At close: Aug 1, 2025, 3:30 PM IST
CTI BioPharma Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 258.53 billion as of August 1, 2025. Its market cap has decreased by -0.53% in one year.
Market Cap
258.53B
Enterprise Value
268.30B
Revenue
78.96B
Ranking
n/a
PE Ratio
37.45
Stock Price
$1,365.70
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 258.53B, an increase of 0.61%. That is a compound annual growth rate of 0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 267.13B | -2.55% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,094.94B |
| Divi's Laboratories | 1,750.90B |
| Cipla | 1,255.73B |
| Apollo Hospitals Enterprise | 1,078.10B |
| Mankind Pharma | 1,059.56B |
| Zydus Lifesciences | 975.85B |
| Aurobindo Pharma | 662.00B |
| Fortis Healthcare | 647.34B |